Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2009, p. 256-260, Vol. 53, No. 1
0066-4804/09/$08.00+0 doi:10.1128/AAC.00470-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Centre for Cellular and Molecular Biology, Council of Scientific and Industrial Research, Uppal Road, Hyderabad 500 007, India
Received 9 April 2008/ Returned for modification 6 July 2008/ Accepted 14 September 2008
The activities of defensins HBD-1, HBD-2, and HBD-3 and their C-terminal analogs Phd1, Phd2, and Phd3 against Candida albicans were investigated. Phd1 to Phd3 showed lower-level activities than HBD-1 to HBD-3, although metabolic inhibitors did not render Phd1 to Phd3 inactive. Their activities were also less salt sensitive than those of HBD-1 to HBD-3. Confocal microscope images indicated that the initial site of action was the fungal membrane.
Published ahead of print on 22 September 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»